Expires August 31, 2019
Length: 49 minutes
This presentation helps guide a new way of thinking about cancer screening using new molecular technology. This technology allows us to reimagine how we screen and how to look at a new screening paradigm because of this technology.
Upon completion of this activity, participants should be able to:
- Identify gaps in our current approach to cancer screening.
- Describe how application of noninvasive molecular tools might fill these gaps and what performance characteristics would be required.
- Assess early data on tumor detection and site prediction with methylated DNA markers.
This program is appropriate for clinicians, pathologists, medical technologists, nurses, pharmacists, and other allied health staff.
Level of Instruction
David Ahlquist, M.D.
Department of Gastroenterology and Hepatology
The following types of credit are offered for our Virtual Lecture programs:
State of California
State of Florida
To obtain credit:
- Watch the video.
- Complete the posttest and evaluation that launches immediately following the video.
- Generate and print your certificate.
For an instruction sheet that describes the process, see http://www.cme-evaluations.com/instructions.pdf.
Note: Participants requesting P.A.C.E.® credit, in compliance with ASCLS P.A.C.E. program requirements, must attain a score of 70% or higher on the posttest to obtain a certificate.
Mayo Medical Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 1.0 P.A.C.E® contact hour.
Mayo Medical Laboratories is approved as a Continuing Education Accrediting Agency for Clinical Laboratory Science for State of California and State of Florida credit. Florida Board of Clinical Laboratory Personnel has designated this program for General credit. The level of instruction for this program is intermediate. This program has been approved for 1.0 contact hour.